Prostate Cancer
Conditions
Keywords
Prostate Cancer, Prostate, Prostate Clinical Trials
Brief summary
Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the participation or completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Prostate Cancer patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might shed insights for the sake of future Prostate Cancer patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient has been diagnosed with Prostate Cancer as identified by imaging * Patient has self-identified as planning to enroll in an interventional clinical trial for Prostate Cancer * Patient is at least 18 years of age
Exclusion criteria
* Patient does not understand, sign, and return consent form * Inability to perform regular electronic reporting * Patient has a ECOG score of 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a Prostate Cancer Clinical Trial | 3 months |
| Number of patients who remain in Prostate Cancer clinical trial until completion of clinical trial | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed